Bonifraterskie Centrum Medyczne Sp. z o.o.

At Bonifraterskie Centrum Medyczne Sp. z o.o. in Lodz, clinical research in digestive system diseases focuses mainly on ulcerative colitis, Crohn’s disease, and erosive esophagitis linked to gastroesophageal reflux disease. These studies are designed to assess how well new treatments can bring symptoms under control, improve healing, and support longer-term disease management.

• Testing new options for inducing remission in ulcerative colitis
• Evaluating safety and tolerability in inflammatory bowel disease
• Comparing treatments for healing and maintenance in erosive esophagitis

The site’s Endoscopy Department is part of this work, supporting research that aims to improve care for people with chronic gastrointestinal conditions.

Research in eye diseases at this hospital includes studies in atrophic age-related macular degeneration, a condition that can gradually affect central vision. The main goal is to evaluate whether new therapies may help slow disease progression and preserve sight.

• Studying treatment effectiveness in geographic atrophy associated with AMD
• Assessing potential to slow vision loss in age-related macular degeneration

This area of research reflects a broader effort to improve options for people living with chronic retinal disease.

Clinical trials in immune system phenomena at Szpital Zakonu Bonifratrów św. Jana Bożego w Łodzi are closely connected to ulcerative colitis and related inflammatory bowel disease. These studies explore whether newer immune-targeted treatments can help patients achieve remission and maintain better disease control over time.

• Evaluating immune-based therapies for ulcerative colitis
• Measuring remission outcomes in chronic inflammatory disease
• Checking long-term safety of novel immune-modulating approaches

The research combines symptom relief goals with careful attention to treatment safety and durability.

Studies in ocular physiological phenomena focus on how new treatments may affect the structure and function of the eye in atrophic AMD. The emphasis is on understanding whether investigational therapies can help protect retinal health and improve outcomes for patients with progressive vision loss.

• Assessing changes in retinal degeneration
• Evaluating approaches to preserve visual function
• Exploring treatment impact in macular disease

These trials support a more detailed understanding of eye function in degenerative retinal conditions.